Latest Breaking News On - Bristol myers squibb reblozyl - Page 3 : comparemela.com

FDA Approves Luspatercept as First-Line Anemia Treatment in Patients With Lower-Risk MDS

The FDA has approved an expanded indication for luspatercept (Reblozl) for the first-line treatment of anemia in patients with low-risk MDS who may require blood transfusions.

United statesGuillermo garcia maneroBristol myers squibb reblozylBristol myers squibbAmerican society of clinical oncology annual meetingUniversity of texas md anderson cancer centerClinical oncology annualMyelodysplastic syndromesCancer center

The Fiji TimesGeron says blood cancer drug succeeds in late-stage study, shares surge

The Fiji TimesGeron says blood cancer drug succeeds in late-stage study, shares surge
fijitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fijitimes.com Daily Mail and Mail on Sunday newspapers.

United statesJohn scarlettStephen willeyBristol myers squibb reblozylIncyte corpDrug administrationGeron corpBristol myers squibbChief executive officer john scarlettCalifornia based geron